Invitae receives court approval for sale to labcorp

Acquisition advances labcorp's specialty testing strategy in key areas such as oncology and rare diseases key milestone reached in invitae's chapter 11 process burlington, n.c. and san francisco , may 7, 2024 /prnewswire/ -- labcorp (nyse: lh), a global leader of innovative and comprehensive laboratory services, and invitae (otc:nvtaq), a leading medical genetics company,  announced today that the united states bankruptcy court has approved the previously announced bid by labcorp to acquire assets of invitae.
LH Ratings Summary
LH Quant Ranking